Search Results

Hypoplastic left heart syndrome has presented many ongoing hardships for Gracie. But this hasn’t stopped her from pressing on.

In 2016, Phoenix Children’s pediatric heart transplant center was the second busiest in the U.S., performing 24 heart transplants as reported by the Scientific Registry of Transplant Recipients (SRTR). This brings the program’s total to 67 transplants since its inception in 2011. The program has seen rapid growth with excellent outcomes.

Phoenix Children’s Hospital is proud to report President and Chief Executive Officer, Robert L. “Bob” Meyer, was recognized as the Phoenix Business Journal’s Lifetime Achievement Award recipient during the publication’s 2019 C-Suite Awards event on November 7.

In a move that strengthens the medical leadership of Phoenix Children’s, the health system today announced a new chief medical officer (CMO) as well as the expansion of the CMO office to include two associate CMOs.

Following Phoenix Children’s recent recognition from the Greater Phoenix Chamber as Exceptional Innovator, Phoenix Children’s was honored as Large Businesses of the Year during the Chamber’s 31st Annual IMPACT Awards Luncheon. Innovation, growth, quality improvement, and a goal to educate are among what leaders at Phoenix Children’s recognize as its major success drivers.

An internationally renowned research scientist at the Phoenix Children’s Research Institute at the University of Arizona College of Medicine – Phoenix has been awarded a multimillion-dollar grant from the National Institutes of Health (NIH) to develop new treatment methods for lung disease in premature infants.

Pediatric patients who have severe forms of lung disease associated with respiratory failure often need transplantable lung tissues and this study proves generating transplantable lungs from stem cells using large animals as bioreactors is possible.